Hydrophobia-canine distemper-canine parvovirus genetic recombination virus strain, construction method and application thereof
A canine parvovirus and gene recombination technology, applied in the field of biological virus vaccine research, can solve the problem of less virus research, and achieve the effect of improving expression and preventing transmission
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] Embodiment 1 (construct rabies-canine distemper-canine parvovirus)
[0023] Construction of rabies-distemper-canine parvovirus gene recombination plasmid, such as figure 1 Shown:
[0024] Rabies SRV 9 Amplify the N, P, M, G, and L genes of the virus;
[0025] The Gibson Assembly connection method was used for recombinant gene connection, and the SRV 9 The G gene of the virus is transferred from the fourth position of the original genome sequence to the second position of the viral genome, and then the eGFP reporter gene is inserted between the G and P genes through the restriction site to construct pcDSRV 9- N-G-eGFP-PML gene recombination vector;
[0026] Amplify the CDV N gene in the canine distemper pMD18-CDV N recombinant plasmid by PCR method;
[0027] pcDSRV by enzyme digestion 9 -N-G-eGFP-PML recombinant vector's eGFP gene terminal restriction site was digested with Hpa I, and the canine distemper CDV N gene was constructed to pcDSRV using the Gibson Assemb...
Embodiment 2
[0032] Embodiment 2 (the recombinant virus of embodiment 1 is rescued by reverse genetic method)
[0033] The rabies-distemper-canine parvovirus (pcDSRV) constructed by reverse genetics 9 -NG-eGFP+CDV N-PM+VP2-L) recombinant plasmids and pcDNA3.1-N, pcDNA3.1-P, pcDNA3.1-M, pcDNA3.1-G and pcDNA3.1-L helper plasmids through lipid The plastid transfection method was co-transfected into BSR cells at a certain concentration, and the rabies-distemper-canine parvovirus "rSRV" was rescued 9 +CDV N+VP2 Gene Recombinant Virus", and RT-PC, indirect immunofluorescence detection.
[0034] (1) Oral immunization of dogs with recombinant rabies virus
[0035] Nine dogs were randomly divided into groups. The first group was the control group injected with the commercially available dog pentavalent inactivated vaccine, and the injection dose was 1mL / dog; the second group was the compound adjuvant + rSRV 9 +CDV N+VP2 gene recombinant virus oral immunization test group, feeding dose of dog 5...
Embodiment 3
[0042] Embodiment 3 (identification of the biological characteristics of the recombinant virus constructed in embodiment 1)
[0043] The rabies "rSRV" that will be constructed 9 +CDV N+VP2” gene recombinant virus, the morphological characteristics of the recombinant virus were observed through an electron microscope; through immunofluorescence experiments, real-time fluorescent quantitative PCR technology, LD 50 In the experiment, the virus titer and virus virulence of the recombinant virus were detected; the antigenicity of the exogenous protein in the virus liquid was qualitatively and quantitatively analyzed by SDS polyacrylamide gel electrophoresis, BCA protein quantification method and Western-blot experiment; Recombinant virus immunization experimental animals (mice and dogs) were tested against rabies-canine distemper-canine parvovirus "rSRV" through double-antibody sandwich ELISA, T lymphocyte transformation test and autologous animal challenge experiment. 9 +CDV N+VP...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com